Plasma bile acids are not associated with energy metabolism in humans

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Brufau, Gemma ^a   Bahr, Matthias J ^b   Staels, Bart ^c,d,e   Claudel, Thierry ^a   Ockenga, Johann ^f   Böker, Klaus H W ^b   Murphy, Elizabeth J ^g,h   Prado, Kris ^g   Stellaard, Frans ^a   Manns, Michael P ^b   Kuipers, Folkert ^a   Tietge, Uwe J F ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIV LILLE   (France)

^d INSTITUT PASTEUR DE LILLE   (France)

^e INSERM   (France)

^f KLINIKUM BREMEN MITTE   (Germany)

^g KINEMED INC   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; BILE ACID SEQUESTRANT; CHENODEOXYCHOLIC ACID; DEOXYCHOLIC ACID;

ADULT; ARTICLE; BILE ACID BLOOD LEVEL; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

MUS;

EID: 77956455354     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-73     Document Type: Article

References (19)

1. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. M Watanabe SM Houten C Mataki MA Christoffolete BW Kim H Sato N Messaddeq JW Harney O Ezaki T Kodama, et al. Nature 2006 439 484 489 10.1038/nature04330 16400329
2. Diagnosis and classification of diabetes mellitus. Diabetes Care 2009 32 Suppl 1 62 S67 19118289
3. Decreased splanchnic oxygen uptake and increased systemic oxygen uptake in cirrhosis are normalized after liver transplantation. UJF Tietge MJ Bahr MP Manns KHW Boker, Liver Transpl 2001 7 1015 1022 10.1053/jlts.2001.29349 11753903
4. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. MJ Bahr J Ockenga KHW Böker MP Manns UJF Tietge, Am J Physiol Endocrinol Metab 2006 291 199 E206 10.1152/ajpendo.00291.2005 16478779
5. Hypermetabolism in clinically stable patients with liver cirrhosis. MJ Muller J Bottcher O Selberg S Weselmann KHW Böker M Schwarze A von zur Mühlen MP Manns, Am J Clin Nutr 1999 69 1194 1201 10357739
6. Measurement of parameters of cholic acid kinetics in plasma using a microscale stable isotope dilution technique: application to rodents and humans. CV Hulzebos L Renfurm RH Bandsma HJ Verkade T Boer R Boverhof H Tanaka I Mierau PJ Sauer F Kuipers F Stellaard, J Lipid Res 2001 42 1923 1929 11714862
7. Enterohepatic circulation of bile salts in farnesoid × receptor-deficient mice: efficient intestinal bile salt absorption in the absence of ileal bile acid-binding protein. T Kok CV Hulzebos H Wolters R Havinga LB Agellon F Stellaard B Shan M Schwarz F Kuipers, J Biol Chem 2003 278 41930 41937 10.1074/jbc.M306309200 12917447
8. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. O Selberg J Bottcher G Tusch R Pichlmayr E Henkel MJ Muller, Hepatology 1997 25 652 657 10.1002/hep.510250327 9049214
9. Body composition, muscle function, and energy expenditure in patients with liver cirrhosis: a comprehensive study. S Peng LD Plank JL McCall LK Gillanders K McIlroy EJ Gane, Am J Clin Nutr 2007 85 1257 1266 17490961
10. Resting energy expenditure in diabetic and nondiabetic patients with liver cirrhosis: relation with insulin sensitivity and effect of liver transplantation and immunosuppressive therapy. G Perseghin V Mazzaferro S Benedini A Pulvirenti J Coppa E Regalia L Luzi, Am J Clin Nutr 2002 76 541 548 12197997
11. Functional brown adipose tissue in healthy adults. KA Virtanen ME Lidell J Orava M Heglind R Westergren T Niemi M Taittonen J Laine NJ Savisto S Enerback P Nuutila, N Engl J Med 2009 360 1518 1525 10.1056/NEJMoa0808949 19357407
12. A G protein-coupled receptor responsive to bile acids. Y Kawamata R Fujii M Hosoya M Harada H Yoshida M Miwa S Fukusumi Y Habata T Itoh Y Shintani, et al. J Biol Chem 2003 278 9435 9440 10.1074/jbc.M209706200 12524422
13. Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. G Vassileva A Golovko L Markowitz SJ Abbondanzo M Zeng S Yang L Hoos G Tetzloff D Levitan NJ Murgolo, et al. Biochem J 2006 398 423 430 10.1042/BJ20060537 16724960
14. Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. T Maruyama K Tanaka J Suzuki H Miyoshi N Harada T Nakamura Y Miyamoto A Kanatani Y Tamai, J Endocrinol 2006 191 197 205 10.1677/joe.1.06546 17065403
15. Body composition and energy expenditure after weight loss following bariatric surgery. G Benedetti G Mingrone S Marcoccia M Benedetti A Giancaterini AV Greco M Castagneto G Gasbarrini, J Am Coll Nutr 2000 19 270 274 10763909
16. Effects of Roux-en-Y gastric bypass on resting energy expenditure in women. M de Castro Cesar MI de Lima Montebelo I Rasera AV de Oliveira PR Gomes Gonelli CG Aparecida, Obes Surg 2008 18 1376 1380 10.1007/s11695-008-9460-8 18320289
17. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. H Nakatani K Kasama T Oshiro M Watanabe H Hirose H Itoh, Metabolism 2009 58 1400 1407 10.1016/j.metabol.2009.05.006 19570554
18. Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism. ME Patti SM Houten AC Bianco R Bernier PR Larsen JJ Holst MK Badman E Maratos-Flier EC Mun J Pihlajamaki, et al. Obesity 2009 17 1671 1677 10.1038/oby.2009.102 19360006
19. TGR5 as a therapeutic target for treating obesity. M Zhong, Curr Top Med Chem 2010 10 386 396 10.2174/156802610790980576 20180762